Daidzein Inhibits Human Platelet Activation by Downregulating Thromboxane A
cardiovascular disease
daidzein
isoflavone
platelet activation
thromboxane A2
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
26 Jul 2023
26 Jul 2023
Historique:
received:
19
06
2023
revised:
17
07
2023
accepted:
24
07
2023
medline:
14
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
Platelets play crucial roles in cardiovascular diseases (CVDs) by regulating hemostasis and blood coagulation at sites of blood vessel damage. Accumulating evidence indicates daidzein inhibits platelet activation, but the mechanism involved has not been elucidated. Thus, in this study, we investigated the mechanism responsible for the inhibition of collagen-induced platelet aggregation by daidzein. We found that in collagen-induced platelets, daidzein suppressed the production of thromboxane A
Identifiants
pubmed: 37569361
pii: ijms241511985
doi: 10.3390/ijms241511985
pmc: PMC10418957
pii:
doi:
Substances chimiques
daidzein
6287WC5J2L
Platelet Aggregation Inhibitors
0
Thromboxanes
0
Collagen
9007-34-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Science and ICT
ID : 2022R1A2C1013203
Références
Cell Death Dis. 2013 Nov 21;4:e931
pubmed: 24263105
Blood Rev. 2015 May;29(3):153-62
pubmed: 25468720
Oxid Med Cell Longev. 2021 Sep 9;2021:6331630
pubmed: 34539970
Front Pharmacol. 2017 Aug 22;8:560
pubmed: 28878675
Int J Mol Sci. 2021 Oct 28;22(21):
pubmed: 34769074
PLoS One. 2012;7(10):e47356
pubmed: 23082158
Eur J Cardiovasc Nurs. 2002 Dec;1(4):273-88
pubmed: 14622657
J Thromb Haemost. 2009 Jul;7(7):1057-66
pubmed: 19422456
J Ginseng Res. 2019 Apr;43(2):236-241
pubmed: 30976161
Biochem Pharmacol. 2000 Oct 15;60(8):1069-74
pubmed: 11007943
Blood. 2008 Jan 15;111(2):658-65
pubmed: 17914025
Br J Clin Pharmacol. 2011 Oct;72(4):634-46
pubmed: 21649691
Biomed Res Int. 2016;2016:9060143
pubmed: 27403440
J Hematol Oncol. 2019 Mar 7;12(1):26
pubmed: 30845955
Nat Med. 2011 Nov 07;17(11):1423-36
pubmed: 22064432
Int J Mol Sci. 2020 Dec 21;21(24):
pubmed: 33371312
Molecules. 2021 Aug 13;26(16):
pubmed: 34443497
J Ginseng Res. 2016 Oct;40(4):359-365
pubmed: 27746688
Br J Clin Pharmacol. 2012 Sep;74(3):396-410
pubmed: 22348281
J Thromb Haemost. 2005 Feb;3(2):369-76
pubmed: 15670046
Agents Actions. 1982 Jul;12(3):382-7
pubmed: 6182778
Mol Pharmacol. 1991 Apr;39(4):475-80
pubmed: 2017148
Front Pharmacol. 2021 Jul 22;12:706363
pubmed: 34366861
Adv Biol Regul. 2015 Sep;59:36-52
pubmed: 26159296
Blood Rev. 2009 Jul;23(4):177-89
pubmed: 19450911
J Cardiovasc Pharmacol. 2002 Sep;40(3):399-410
pubmed: 12198326
J Blood Med. 2022 May 25;13:267-274
pubmed: 35642190
J Clin Invest. 2005 Dec;115(12):3363-9
pubmed: 16322781
Int J Mol Sci. 2023 Jan 10;24(2):
pubmed: 36674864
Int J Mol Sci. 2022 Jan 29;23(3):
pubmed: 35163507
Circulation. 2021 Mar 16;143(11):1157-1172
pubmed: 33720773
Front Endocrinol (Lausanne). 2013 Jun 26;4:77
pubmed: 23805129
Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):60-74
pubmed: 24062891
Biochem Pharmacol. 2021 Jun;188:114519
pubmed: 33737052
Curr Med Chem. 2010;17(26):2897-905
pubmed: 20858171
Blood. 2000 Sep 1;96(5):1798-807
pubmed: 10961879
Methods Mol Biol. 2012;788:101-7
pubmed: 22130703
Int J Hematol Oncol Stem Cell Res. 2017 Oct 1;11(4):319-327
pubmed: 29340130
Arthritis Res Ther. 2005;7 Suppl 4:S14-22
pubmed: 16168077
F1000Res. 2018 Feb 28;7:236
pubmed: 29560259
Blood. 2009 Jan 22;113(4):893-901
pubmed: 18957688
Front Pharmacol. 2021 Apr 15;12:648636
pubmed: 33935751